FDA Completes Office Of Compliance Reorganization
This article was originally published in The Gray Sheet
Executive Summary
The office now contains five divisions, several of which are new, emphasizing a function-based rather than product-based organizational focus, officials say.
You may also be interested in...
CDRH Office Of Compliance Shifts To “Function-Based Structure”
FDA’s device center Office of Compliance is reorganizing. Major goals are to organize staff around functions rather than product categories, increase attention to underserved areas and strengthen the office’s international focus.
CDRH To Beef Up Monitoring Of Device Ads And Promotions
CDRH will expand its staff devoted to monitoring device advertising and promotions activity as part of a reorganization of its Office of Compliance.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.